Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis.

Mogire RM, Mutua A, Kimita W, Kamau A, Bejon P, Pettifor JM, Adeyemo A, Williams TN, Atkinson SH.

Lancet Glob Health. 2020 Jan;8(1):e134-e142. doi: 10.1016/S2214-109X(19)30457-7. Epub 2019 Nov 27.

2.

The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Muriuki JM, Mentzer AJ, Band G, Gilchrist JJ, Carstensen T, Lule SA, Goheen MM, Joof F, Kimita W, Mogire R, Cutland CL, Diarra A, Rautanen A, Pomilla C, Gurdasani D, Rockett K, Mturi N, Ndungu FM, Scott JAG, Sirima SB, Morovat A, Prentice AM, Madhi SA, Webb EL, Elliott AM, Bejon P, Sandhu MS, Hill AVS, Kwiatkowski DP, Williams TN, Cerami C, Atkinson SH.

Sci Adv. 2019 Sep 4;5(9):eaaw0109. doi: 10.1126/sciadv.aaw0109. eCollection 2019 Sep.

3.

Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions.

Miller Iii WA, Teye J, Achieng AO, Mogire RM, Akala H, Ong'echa JM, Rathi B, Durvasula R, Kempaiah P, Kwofie SK.

Curr Top Med Chem. 2019;18(23):2022-2028. doi: 10.2174/1568026619666181130133548. Review.

PMID:
30499404
4.

Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei.

Onchieku NM, Mogire R, Ndung'u L, Mwitari P, Kimani F, Matoke-Muhia D, Kiboi D, Magoma G.

PLoS One. 2018 Aug 1;13(8):e0201556. doi: 10.1371/journal.pone.0201556. eCollection 2018.

5.

Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.

Mogire RM, Akala HM, Macharia RW, Juma DW, Cheruiyot AC, Andagalu B, Brown ML, El-Shemy HA, Nyanjom SG.

PLoS One. 2017 Oct 31;12(10):e0186364. doi: 10.1371/journal.pone.0186364. eCollection 2017.

Supplemental Content

Loading ...
Support Center